Gene Editing
Overview
R&D Platforms
Manufacturing
Papers & Presentations
Our Pipeline
Our Pipeline
Ex Vivo
Therapies
In Vivo
Therapies
Our Focus
Genetic Diseases
Cancer
About Us
Company Overview
Scientific Founder
Leadership
Contact Us
Careers
Company Culture
Join Us
News
Press Releases
In the Media
简体中文
中文
Edit Code of Life,
Creating Transformative Solutions for Serious Human Diseases
Press Releases
In the Media
>
News
>
In the Media
Out to pioneer gene editing in China, EdiGene bags $67M to begin clinical testing for β-thalassemia therapy, universal CAR-T
Time:20-10-13 08:00
Form: Null
Views:32
Endpoints - Amber Tong
Return